JnJ seeks USFDA approval for Tremfya for moderately to severely active Crohn's disease Ruchika Sharma22 Jun 2024 2:21 PM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
US judge halts most talc lawsuits against Johnson and Johnson Ruchika Sharma21 April 2023 2:15 PM ISTLTL Management argued that allowing litigation against J&J to continue would imperil current settlement efforts.
Janssen seeks USFDA nod for Niraparib and Abiraterone Acetate Dual-Action Tablet, plus Prednisone to treat patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Gene Mutations Ruchika Sharma2 March 2023 3:15 PM ISTMetastatic castration-resistant prostate cancer characterizes cancer that no longer responds to androgen deprivation therapy and has spread to other...
JnJ to terminate COVID vaccine agreement with Emergent BioSolutions Ruchika Sharma7 Jun 2022 4:33 PM ISTIf the agreement is terminated, Emergent said J&J would owe it roughly $125 million to $420 million.
Janssen Pharma launches icare4u program for skin, joint, digestive disorders Ruchika Sharma22 May 2022 9:00 AM ISTMumbai: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the launch of icare4u, a comprehensive program to support the...
J&J says its single dose protects against breakthrough COVID-19 for up to 6 months Medical Dialogues Bureau10 Jan 2022 2:30 PM ISTJohnson & Johnson (JNJ.N) said on Thursday that a real-world study showed its single shot COVID-19 vaccine protects against breakthrough...
Johnson and Johnson to split into 2 companies Medical Dialogues Team13 Nov 2021 5:01 PM ISTNew Delhi: US pharma giant Johnson and Johnson (JnJ) has recently announced that it is splitting into two companies, separating the division that...
Johnson and Johnson 1-dose shot prevents COVID-19, says FDA Ruchika Sharma25 Feb 2021 1:27 PM ISTNew Delhi: Johnson & Johnson's single-dose vaccine protects against Covid-19, according to an analysis by U.S. regulators Wednesday that sets the...
UK to run final stage trials of Johnson and Johnson arm Covid vaccine Ruchika Sharma17 Nov 2020 9:30 AM ISTLondon: Britain will be the first country to run final stage trials of an experimental coronavirus vaccine being developed by the pharmaceutical...
Johnson and Johnson gets EU nod to supply 200 million doses of COVID Vaccine Ruchika Sharma9 Oct 2020 1:19 PM ISTNew Brunswick: Johnson & Johnson has recently announced the European Commission (EC), acting on behalf of the European Union (EU) Member States,...
JnJ vaccine raises neutralizing antibodies, prevents severe COVID-19 in hamsters Ruchika Sharma6 Sept 2020 10:45 AM ISTThe vaccine, co-developed by the Beth Israel Deaconess Medical Center and Johnson & Johnson (JnJ), uses a common cold virus, called adenovirus...
Pharma Deal of the year: Johnson & Johnson to acquire Momenta for 6.5 billion USD Ruchika Sharma21 Aug 2020 3:14 PM ISTUS: Johnson & Johnson agreed to pay $6.5 billion in cash to acquire Momenta Pharmaceuticals Inc., a maker of autoimmune-disease drugs, in the...
